A clinicopathological review of 33 patients with vulvar melanoma identifies c-KIT as a prognostic marker
暂无分享,去创建一个
N. Hacker | G. Otton | J. Scurry | S. Nixdorf | A. Fedier | V. Heinzelmann-Schwarz | J. Olivier | M. Valadan | Monica Diczbalis
[1] J. Kirkwood,et al. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] He Huang,et al. Clinical outcome of 31 patients with primary malignant melanoma of the vagina , 2013, Journal of gynecologic oncology.
[3] R. Ali-Fehmi,et al. Vulvar/Vaginal Melanoma: An Updated Surveillance Epidemiology and End Results Database Review, Comparison With Cutaneous Melanoma and Significance of Racial Disparities , 2013, International Journal of Gynecologic Cancer.
[4] K. Vousden,et al. p53 mutations in cancer , 2013, Nature Cell Biology.
[5] A. Abernethy,et al. Clinicopathologic study of 85 cases of melanoma of the female genitalia. , 2012, Journal of the American Academy of Dermatology.
[6] R. Dummer,et al. Sinonasal, genital and acrolentiginous melanomas show distinct characteristics of KIT expression and mutations. , 2012, European journal of cancer.
[7] H. Kluger,et al. Driver Mutations in Melanoma: Lessons Learned From Bench-to-Bedside Studies , 2012, Current Oncology Reports.
[8] N. Normanno,et al. The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches , 2012, Expert opinion on therapeutic targets.
[9] M. Postow,et al. Therapeutic Implications of KIT in Melanoma , 2012, Cancer journal.
[10] L. Kanter‐Lewensohn,et al. KIT Pathway Alterations in Mucosal Melanomas of the Vulva and Other Sites , 2011, Clinical Cancer Research.
[11] B. Ragnarsson-Olding. Spatial density of primary malignant melanoma in sun-shielded body sites: A potential guide to melanoma genesis , 2011, Acta oncologica.
[12] J. Moan,et al. Where the sun does not shine: is sunshine protective against melanoma of the vulva? , 2010, Journal of photochemistry and photobiology. B, Biology.
[13] J. Tabernero,et al. Targeting the PI3K/Akt/mTOR Pathway – Beyond Rapalogs , 2010, Oncotarget.
[14] M. van Beurden,et al. Premalignant epithelial disorders of the vulva: squamous vulvar intraepithelial neoplasia, vulvar Paget's disease and melanoma in situ , 2010, Acta obstetricia et gynecologica Scandinavica.
[15] D. Hu,et al. Population-based incidence of vulvar and vaginal melanoma in various races and ethnic groups with comparisons to other site-specific melanomas , 2010, Melanoma research.
[16] A. Dobrovic,et al. Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure , 2010, Pigment cell & melanoma research.
[17] L. Travaini,et al. Sentinel node detection by lymphoscintigraphy and sentinel lymph node biopsy in vulvar melanoma , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[18] G. Giraud,et al. DNA from BK Virus and JC Virus and from KI, WU, and MC Polyomaviruses as Well as from Simian Virus 40 Is Not Detected in Non-UV-Light-Associated Primary Malignant Melanomas of Mucous Membranes , 2008, Journal of Clinical Microbiology.
[19] P. Buccini,et al. Vulvar melanoma: a report of 10 cases and review of the literature , 2008, Melanoma research.
[20] M. Koppán,et al. Is the clinical staging system a good choice in the staging of vulvar malignancies? , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[21] J. Berek,et al. Vulvar Melanoma: A Multivariable Analysis of 644 Patients , 2007, Obstetrics and gynecology.
[22] R. Woolas,et al. Utility of sentinel node biopsy in vulvar and vaginal melanoma: report of two cases and review of the literature. , 2007, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
[23] L. Kanter‐Lewensohn,et al. Human herpes virus DNA is rarely detected in non-UV light-associated primary malignant melanomas of mucous membranes. , 2006, Anticancer research.
[24] Jennifer L. Schwartz,et al. Vulvar melanoma in a 10-year-old girl in association with lichen sclerosus. , 2006, Journal of the American Academy of Dermatology.
[25] L. Kanter‐Lewensohn,et al. Human papilloma virus (HPV) is rarely detected in malignant melanomas of sun sheltered mucosal membranes , 2005, Acta oncologica.
[26] Kevin B. Kim,et al. Biochemotherapy in patients with advanced vulvovaginal mucosal melanoma , 2004, Melanoma research.
[27] U. Ringborg,et al. p53 protein expression and TP53 mutations in malignant melanomas of sun-sheltered mucosal membranes versus chronically sun-exposed skin , 2004, Melanoma research.
[28] B. Ragnarsson-Olding. Primary malignant melanoma of the vulva An aggressive tumor for modeling the genesis of Non-UV light-associated melanomas , 2004, Acta oncologica.
[29] N. Hardt,et al. Malignant Melanoma Associated with Lichen Sclerosus in the Vulva of a 10‐Year‐Old , 2004, Pediatric dermatology.
[30] H. Kerl,et al. Genital lentigines and melanocytic nevi with superimposed lichen sclerosus: a diagnostic challenge. , 2004, Journal of the American Academy of Dermatology.
[31] Jennifer L. Schwartz,et al. Vulvar melanoma: a report of 20 cases and review of the literature. , 2004, Journal of the American Academy of Dermatology.
[32] B. Weber,et al. Absence of BRAF mutations in UV-protected mucosal melanomas , 2004, Journal of Medical Genetics.
[33] M. Finan,et al. Bartholin's gland carcinoma, malignant melanoma and other rare tumours of the vulva. , 2003, Best practice & research. Clinical obstetrics & gynaecology.
[34] U. Ringborg,et al. Mutations in the TP53 gene in human malignant melanomas derived from sun-exposed skin and unexposed mucosal membranes , 2002, Melanoma research.
[35] Joanne A. de Hullu,et al. Vulvar melanoma , 2002, Cancer.
[36] M. Stoler,et al. Vulvar melanoma: a retrospective analysis and literature review. , 2001, Gynecologic oncology.
[37] M. Ross,et al. Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years later , 2001, International Journal of Gynecologic Cancer.
[38] C. Balch. New melanoma staging system , 2001, Journal of the National Cancer Institute.
[39] M. Atkins,et al. High-dose interferon alfa-2b does not diminish antibody response to GM2 vaccination in patients with resected melanoma: results of the Multicenter Eastern Cooperative Oncology Group Phase II Trial E2696. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] D. Paladini,et al. Prognostic Indicators in Melanoma of the Vulva , 2000, Annals of Surgical Oncology.
[41] C. Dunton,et al. Vulvar melanoma, biologically different from other cutaneous melanomas , 1999, The Lancet.
[42] L. Kanter‐Lewensohn,et al. Malignant melanoma of the vulva in a nationwide, 25‐year study of 219 Swedish females , 1999, Cancer.
[43] H. Menck,et al. A survey of hospital management practices for vulvar melanoma. , 1999, Journal of the American College of Surgeons.
[44] J. Scurry. Does lichen sclerosus play a central role in the pathogenesis of human papillomavirus negative vulvar squamous cell carcinoma? The itch-scratch-lichen sclerosus hypothesis. , 1999, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
[45] J. Thompson,et al. Primary mucosal and glans penis melanomas: the Sydney Melanoma Unit experience. , 1999, The Australian and New Zealand journal of surgery.
[46] U. Ringborg,et al. N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin. , 1998, The Journal of investigative dermatology.
[47] D. Tyler,et al. Mucosal melanoma of the female genitalia: a clinicopathologic study of forty-three cases at Duke University Medical Center. , 1998, Surgery.
[48] B. Strauss. Silent and multiple mutations in p53 and the question of the hypermutability of tumors. , 1997, Carcinogenesis.
[49] S. Vanderhooft,et al. Vulvar melanoma in childhood. , 1997, Archives of dermatology.
[50] V. Abeler,et al. Malignant melanoma of the vulva FIGO stage I: Evaluation of prognostic factors in 43 patients with emphasis on DNA ploidy and surgical treatment. , 1996, Gynecologic oncology.
[51] C. Dunton,et al. Malignant melanoma of the vulva: a review. , 1995, Obstetrical & gynecological survey.
[52] B. Bundy,et al. Malignant melanoma of the vulva treated by radical hemivulvectomy. A prospective study of the gynecologic oncology group , 1994, Cancer.
[53] G. Sutton,et al. Blood transfusion and the risk of recurrence in squamous carcinoma of the vulva. , 1993, American journal of obstetrics and gynecology.
[54] U. Ringborg,et al. Malignant melanoma of the vulva and vagina. Trends in incidence, age distribution, and long‐term survival among 245 consecutive cases in Sweden 1960–1984 , 1993 .
[55] A. Lopes,et al. Malignant melanoma of the vulva: A clinicopathologic study of 18 cases , 1992, Journal of surgical oncology.
[56] E. P. van der Esch,et al. A clinicopathological study of 30 melanomas of the vulva , 1992, Gynecologic oncology.
[57] E. Trimble,et al. Management of vulvar melanoma. , 1992, Gynecologic oncology.
[58] N. Kernohan,et al. Subungual malignant melanoma: clinicopathological features of 100 cases , 1991, Histopathology.
[59] E. Weiser,et al. Surgery for vulvar cancer. , 1991, The Surgical clinics of North America.
[60] T. Rollason,et al. Malignant melanoma of the vulva: A clinicopathological study of 50 women , 1990 .
[61] Henry Rj,et al. Malignant melanoma of the vulva. Australian experience. , 1988 .
[62] U. Beller,et al. Vulvovaginal melanoma. A clinicopathologic study. , 1986, The Journal of reproductive medicine.
[63] B. Sevin,et al. Malignant Melanoma of the Vulva , 1985, Obstetrics and gynecology.
[64] K. Podratz,et al. Melanoma of the vulva: an update. , 1983, Gynecologic oncology.
[65] J. Woodruff,et al. Malignant melanoma of the vulva: A report of 44 cases. , 1975, Obstetrics and gynecology.
[66] A Breslow,et al. Thickness, Cross‐Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous Melanoma , 1970, Annals of surgery.
[67] Ralph,et al. A Clinicopathologic Study , 2006 .
[68] R. Neves,et al. Vulvar melanoma: report on eleven cases and review of the literature. , 2010, Sao Paulo medical journal = Revista paulista de medicina.
[69] G. C. Guimarães,et al. Melanoma de vulva: Relato de onze casos e revisão da literatura , 2010 .
[70] A. Stang,et al. Population-based incidence rates of malignant melanoma of the vulva in Germany. , 2005, Gynecologic oncology.
[71] C. Kreibich,et al. Lichen sclerosus , 2005, Archiv für Dermatologie und Syphilis.
[72] J. Kirkwood,et al. An update on adjuvant interferon for melanoma. , 2002, Cancer control : journal of the Moffitt Cancer Center.
[73] M. Mihm,et al. Melanocytic proliferations associated with lichen sclerosus. , 2002, Archives of dermatology.
[74] C. Jackisch,et al. Malignant melanoma of the vulva. Report of 89 patients. , 1996, Cancer.
[75] V. Abeler,et al. Malignant melanoma of the vulva. Evaluation of prognostic factors with emphasis on DNA ploidy in 75 patients , 1995, Cancer.
[76] U. Ringborg,et al. Malignant Melanoma of the Vulva and Vagina: Trends in Incidence, Age Distribution, and Long-Term Survival Among 245 Consecutive Cases in Sweden, 1960–1984 , 1994 .
[77] C. Houghton,et al. Malignant melanoma of the vulva. Australian experience. , 1988, The Journal of reproductive medicine.
[78] A. Kopf,et al. Malignant melanoma in association with lichen sclerosus on the vulva of a 14-year-old. , 1984, The American Journal of dermatopathology.
[79] Jones Wb,et al. Malignant melanoma in association with lichen sclerosus on the vulva of a 14-year-old. , 1984 .
[80] M. Harris,et al. Epidermotropically metastatic malignant melanoma. Differentiating malignant melanoma metastatic to the epidermis from malignant melanoma primary in the epidermis. , 1978, Archives of dermatology.
[81] W. Plate. [Malignant melanoma of the vulva]. , 1949, Nederlandsch tijdschrift voor verloskunde en gynaecologie.